This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Berry DA, Ueno NT, Johnson MM, Lei X, Caputo J, Rodenhuis S et al. High dose chemotherapy with autologous stem cell support versus standard-dose chemotherapy: overview of individual patient data from 15 randomized adjuvant therapy breast cancer trials. J Clin Oncol 2011; 29: 3214–3223.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Demirer, T. Response to: ‘Are there still reasons to believe that high-dose chemotherapy plays a role in breast cancer management?’. Bone Marrow Transplant 48, 306 (2013). https://doi.org/10.1038/bmt.2012.127
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2012.127